Laurion Capital Management LP Pyxis Oncology, Inc. Transaction History
Laurion Capital Management LP
- $8.4 Billion
- Q2 2024
A detailed history of Laurion Capital Management LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 3,861,179 shares of PYXS stock, worth $14.6 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,861,179
Previous 3,861,179
-0.0%
Holding current value
$14.6 Million
Previous $16.4 Million
22.3%
% of portfolio
0.15%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding PYXS
# of Institutions
89Shares Held
28.7MCall Options Held
134KPut Options Held
5K-
Deep Track Capital, LP Greenwich, CT4.18MShares$15.8 Million0.45% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$10.5 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.56MShares$9.66 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$7.77 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.66MShares$6.27 Million2.23% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $132M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...